Hukkelhoven Mathias 4
4 · Centessa Pharmaceuticals plc · Filed Jul 6, 2022
Insider Transaction Report
Form 4
Hukkelhoven Mathias
Director
Transactions
- Award
Share Option (right to buy)
2022-07-01+96,000→ 96,000 totalExercise: $5.17Exp: 2032-07-01→ Ordinary Shares (96,000 underlying)
Footnotes (2)
- [F1]The shares subject to such option will vest in 36 equal monthly installments over three years from the grant date, subject to continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.